Softwr

Healthcare · head to head

Fullscript vs PathAI

Fullscript logo

Fullscript

Healthcare

Supplement dispensing for practitioners, free to use because it earns on the products

From
Free
Rated
-
Full reviewWebsite
PathAI logo

PathAI

Healthcare

Digital pathology image management with an FDA cleared platform for primary diagnosis

From
On request
Rated
-
Full reviewWebsite

The short version

  • Only Fullscript has a free tier, so it costs nothing to try first.
  • Each has a real cost: Fullscript the practitioner sets their own margin on products they clinically recommend, which is a conflict of interest that some professional bodies and patients view badly, and the platform makes the arrangement easy rather than making it visible.; PathAI aISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.
  • They diverge on capability: Fullscript covers Protocol dispensing, PathAI covers AISight image management.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Fullscript and PathAI actually diverge.

Attributes where Fullscript and PathAI differ
AttributeFullscriptPathAI
Starting priceFreeOn request
Pricing modelPer user per monthquote
Free tierYesNo
PlatformsWeb, iOS, AndroidWeb

Identical on both: user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Fullscript

  • Protocol dispensing
  • Profit dispensary
  • Auto refill
  • Lab ordering
  • Patient app
  • EHR integration
  • Enterprise catalogue control

Only in PathAI

  • AISight image management
  • AISight Dx
  • Scanner interoperability
  • Case and worklist management
  • AI algorithm deployment
  • Biopharmaceutical research tooling
  • LIS integration

What people use each for

The jobs each tool is most often brought in to do.

Fullscript

  • A functional medicine practice that wants to stop holding supplement stock, cash and expiry risk in the clinicnot PathAI
  • A dietitian or naturopath adding a dispensary revenue stream without buying inventory upfrontnot PathAI
  • A clinic that needs patients to actually keep taking a protocol, where auto refills and dose reminders address the adherence problem directlynot PathAI
  • A multi site integrative health group that wants a single approved catalogue rather than each clinician choosing their own brandsnot PathAI

PathAI

  • An academic medical centre going digital for primary diagnosis that needs the FDA cleared AISight Dx configuration rather than the research labelled versionnot Fullscript
  • A reference laboratory consolidating subspecialty sign out across sites so a specialist pathologist can read cases from any locationnot Fullscript
  • A pharmaceutical company needing consistent quantitative scoring of trial biopsies across many sites and readersnot Fullscript
  • A laboratory with a mixed scanner estate that needs one image management layer rather than each scanner vendor viewernot Fullscript

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Fullscript

  • The practitioner sets their own margin on products they clinically recommend, which is a conflict of interest that some professional bodies and patients view badly, and the platform makes the arrangement easy rather than making it visible.
  • The account is free but the practice does not control pricing, catalogue, shipping cost or the patient discount, so the entire economics of the dispensary can be changed by the vendor without the practice having any lever.
  • Converting to a profit account requires personal identity verification, tax details and a bank account, and makes dispensary earnings the practitioner personal taxable income to report, which is administrative work no one warns about at signup.
  • Product availability and shipping are geographically limited, so practices outside the supported countries cannot use it at all and cross border patients will find items unavailable at checkout.
  • Patient refill schedules, plan history and a slice of practice revenue accumulate inside a platform the practice cannot export in a form another dispensary would accept, so switching later means asking every patient to re-enrol somewhere else.

PathAI

  • AISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.
  • The software licence is usually the smallest line in a digital pathology project, behind scanners, storage and network capacity, so a business case built around the software cost understates the real investment by a wide margin.
  • Whole slide images are very large, so a laboratory that does not model storage growth and retention policy from the start faces storage costs that grow faster than case volume and dominate the renewal.
  • Clinical validation is required per subspecialty rather than once for the platform, which means dermatopathology, gastrointestinal and breast each need their own concordance study and pathologist time before go live.
  • PathAI competes against pathology incumbents that also sell the scanners, and a laboratory buying an independent image management layer takes on the integration risk between scanner vendor and software vendor itself.

Pricing, plan by plan

Fullscript

Free
  • PractitionerFree
    • Full catalogue and dispensing at no account fee
    • Lab ordering and results
    • Standard EHR integrations
  • PatientFree
    • No account fee
    • Mobile app with dose reminders
    • Auto refills, cancellable at any time
  • Enterprise$undefined/year
    • Quoted for health systems and multi site groups
    • Centrally managed catalogue with quality standards
    • API level EHR integration

PathAI

On request
  • AISight$undefined/year
    • Priced by annual slide or case volume and by pathologist seats
    • AISight Dx, the clinically cleared configuration, quoted separately from research use AISight
    • Image storage priced by capacity and retention policy

Which should you pick?

Choose Fullscript if

  • You need protocol dispensing.
  • You want to start without paying.
  • You work on Web, iOS, Android.
  • You also want profit dispensary.
Fullscript review

Choose PathAI if

  • You need aisight image management.
  • You also want aisight dx.
PathAI review

Questions people ask

Is Fullscript or PathAI better?
Neither clearly leads. Fullscript starts at Free and PathAI at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Fullscript or PathAI?
Fullscript has a free tier; the other does not. Paid plans start at Free for Fullscript and On request for PathAI.
Does Fullscript or PathAI run on more platforms?
Fullscript runs on Web, iOS, Android. PathAI runs on Web.
Can I use Fullscript for free?
Yes. Fullscript has a free tier, so you can try it without paying. PathAI starts at On request.
What is Fullscript best used for?
Fullscript is most often used for a functional medicine practice that wants to stop holding supplement stock, cash and expiry risk in the clinic, a dietitian or naturopath adding a dispensary revenue stream without buying inventory upfront, a clinic that needs patients to actually keep taking a protocol, where auto refills and dose reminders address the adherence problem directly, a multi site integrative health group that wants a single approved catalogue rather than each clinician choosing their own brands. Of those, a functional medicine practice that wants to stop holding supplement stock, cash and expiry risk in the clinic and a dietitian or naturopath adding a dispensary revenue stream without buying inventory upfront are not what PathAI is typically brought in for.
What can Fullscript do that PathAI cannot?
Fullscript covers Protocol dispensing, Profit dispensary, Auto refill, Lab ordering. PathAI covers AISight image management, AISight Dx, Scanner interoperability, Case and worklist management.

Answered from the vendors’ own pages

Fullscript: Is Fullscript really free for practitioners?

Yes, the account has no fee. Fullscript earns on the supplements sold through it, and a practitioner on a profit account also earns a margin on those sales.

PathAI: What is the difference between AISight and AISight Dx?

AISight is for research use only and not for clinical diagnostic use. AISight Dx received FDA 510(k) clearance in June 2025 for primary diagnosis and is CE-IVD marked in the EEA, UK and Switzerland. Only the Dx configuration can be used to sign out cases.

Fullscript: How do practitioners make money on it?

By converting to a profit dispensary and setting a margin. That requires tax information and a bank account, and the earnings are taxable income.

PathAI: Can we use our existing scanners?

Yes. AISight is designed to ingest images from multiple whole slide scanner vendors, which is one of the main reasons laboratories choose an independent image management layer.

Fullscript: What do patients pay?

No account fee, and a ten per cent discount on orders if the practitioner runs a no profit dispensary rather than taking a margin.

PathAI: Do the AI algorithms carry the same clearance as the platform?

No. The platform clearance covers image management for primary diagnosis. Individual algorithms have their own labelling, and many are research use only. Check each one separately.

Fullscript: Is there an enterprise option?

Yes, quoted for health systems, adding central catalogue control, API EHR integration and cross site reporting.

PathAI: Is pricing published?

No. It is quoted by slide or case volume, pathologist seats and storage, with the clinically cleared configuration priced separately.

Share

Related pages

More on Fullscript

More on PathAI

Keep looking

Other head to heads